Ascendis Pharma A (ASND) Current Assets (2012 - 2026)

Ascendis Pharma A has reported Current Assets for 15 years, with the latest figure at $1.3 billion in Q1 2026.

• Quarterly Current Assets rose 35.56% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 35.56% YoY) and the FY2025 annual result came in at $1.3 billion, up 66.06% from the prior year.
• Current Assets advanced to $1.3 billion in Q1 2026 per ASND's latest filing, from $1.3 billion in the prior quarter.
• Over five years, Current Assets peaked at $1.3 billion in Q1 2026 and troughed at $675.6 million in Q2 2024.
• A 5-year average of $983.7 million and a median of $969.3 million in 2025 frame the typical range for Current Assets.
• The sharpest annual moves came in 2022 and 2023: Current Assets surged 68.66% in 2022, then plunged 37.81% in 2023.
• Over 5 years, Current Assets stood at $942.2 million in 2022, then fell by 19.75% to $756.1 million in 2023, then climbed by 2.82% to $777.4 million in 2024, then soared by 66.06% to $1.3 billion in 2025, then grew by 1.79% to $1.3 billion in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $1.3 billion, $1.3 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.